DEA Rescheduling Hearing Cancelled After Interlocutory Appeal
Key Takeaway
DEA Administrative Law Judge John Mulrooney granted an interlocutory appeal filed by cannabis rescheduling opponents, cancelling the public hearing that had been scheduled to debate moving cannabis from Schedule I to Schedule III. The cancellation effectively paused the entire rescheduling process, which had been working its way through the DEA since HHS recommended the move in August 2023. The hearing was expected to be the most significant public debate on federal cannabis policy in 50 years. For cannabis operators, the procedural delay extended Section 280E tax exposure and pushed any meaningful federal tax relief further into the future, reinforcing that rescheduling would not be a quick fix.
What This Means for Cannabis Businesses
Federal policy changes ripple across the entire cannabis industry. Whether it's rescheduling progress, banking legislation, or court rulings, these developments shape the operating environment for businesses in every legal state. Operators should monitor these developments closely and consult with their legal counsel to understand the implications for their specific markets and operations.
Related Guides
Find Help
Related News
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
New Congressional Research Report on Cannabis Rescheduling Published
Congressional Research Service Releases Comprehensive Cannabis Rescheduling Report
Federal Government Warns About Cannabis and Hemp in Drug Tests
This analysis is based on reporting by Cannabis Business Times. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.